Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

United Therapeutics (UTHR) Other Gross PP&E Adjustments (2016 - 2025)

United Therapeutics' Other Gross PP&E Adjustments history spans 16 years, with the latest figure at $2.3 billion for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 34.07% year-over-year to $2.3 billion; the TTM value through Dec 2025 reached $2.3 billion, up 34.07%, while the annual FY2025 figure was $2.3 billion, 34.07% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $2.3 billion at United Therapeutics, up from $2.1 billion in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $2.3 billion in Q4 2025 and bottomed at $1.0 billion in Q1 2021.
  • The 5-year median for Other Gross PP&E Adjustments is $1.4 billion (2023), against an average of $1.5 billion.
  • The largest annual shift saw Other Gross PP&E Adjustments increased 7.92% in 2021 before it surged 34.07% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $1.1 billion in 2021, then rose by 10.76% to $1.2 billion in 2022, then increased by 18.44% to $1.5 billion in 2023, then rose by 16.29% to $1.7 billion in 2024, then skyrocketed by 34.07% to $2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Other Gross PP&E Adjustments are $2.3 billion (Q4 2025), $2.1 billion (Q3 2025), and $1.9 billion (Q2 2025).